WINNIPEG, MANITOBA--(Marketwire - December 03, 2007) - DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and development company focused on novel treatments for type 2 diabetes, is pleased to announce that it has been named as one of Canada's Top 10 Life Science Companies.
